Literature DB >> 19922970

Humanized Rag2(-/-)gammac(-/-) (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year.

Bradford K Berges1, Sarah R Akkina, Leila Remling, Ramesh Akkina.   

Abstract

HIV-1 infection is characterized by life-long viral persistence and continued decline of helper CD4 T cells. The new generation of humanized mouse models that encompass RAG-hu, hNOG and BLT mice have been shown to be susceptible to HIV-1 infection and display CD4 T cell loss. Productive infection has been demonstrated with both R5 and X4 tropic strains of HIV-1 via direct injection as well as mucosal exposure. However the duration of infection in these mice was evaluated for a limited time lasting only weeks post infection, and it is not established how long the viremia can be sustained, and if the CD4 T cell loss persists throughout the life of the infected humanized mice. In the present study we followed the HIV-1 infected RAG-hu mice to determine the long-term viral persistence and CD4 T cell levels. Our results showed that viremia persists life-long lasting for more than a year, and that CD4 T cell levels display a continuous declining trend as seen in the human. These studies provide a chronic HIV-1 infection humanized mouse model that can be used to dissect viral latency, long-term drug evaluation and immune-based therapies. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922970      PMCID: PMC3622870          DOI: 10.1016/j.virol.2009.10.034

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

1.  Development of a human adaptive immune system in cord blood cell-transplanted mice.

Authors:  Elisabetta Traggiai; Laurie Chicha; Luca Mazzucchelli; Lucio Bronz; Jean-Claude Piffaretti; Antonio Lanzavecchia; Markus G Manz
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

Review 2.  Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice.

Authors:  D E Mosier
Journal:  Adv Immunol       Date:  1996       Impact factor: 3.543

Review 3.  The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS.

Authors:  B D Jamieson; G M Aldrovandi; J A Zack
Journal:  Semin Immunol       Date:  1996-08       Impact factor: 11.130

4.  Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.

Authors:  Francois Rouet; Didier K Ekouevi; Marie-Laure Chaix; Marianne Burgard; Andre Inwoley; Thomas D'Aquin Tony; Christine Danel; Xavier Anglaret; Valeriane Leroy; Philippe Msellati; Francois Dabis; Christine Rouzioux
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.

Authors:  M Tersmette; R A Gruters; F de Wolf; R E de Goede; J M Lange; P T Schellekens; J Goudsmit; H G Huisman; F Miedema
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.

Authors:  Jes G Kuruvilla; Ryan M Troyer; Shamala Devi; Ramesh Akkina
Journal:  Virology       Date:  2007-08-16       Impact factor: 3.616

7.  Human-hemato-lymphoid-system mice: opportunities and challenges.

Authors:  Markus G Manz
Journal:  Immunity       Date:  2007-05       Impact factor: 31.745

8.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.

Authors:  J M McCune; R Namikawa; H Kaneshima; L D Shultz; M Lieberman; I L Weissman
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

9.  Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse.

Authors:  R K Akkina; J D Rosenblatt; A G Campbell; I S Chen; J A Zack
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

10.  Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.

Authors:  Paul W Denton; Jacob D Estes; Zhifeng Sun; Florence A Othieno; Bangdong L Wei; Anja K Wege; Daniel A Powell; Deborah Payne; Ashley T Haase; J Victor Garcia
Journal:  PLoS Med       Date:  2008-01-15       Impact factor: 11.069

View more
  36 in total

1.  HIV latency in the humanized BLT mouse.

Authors:  Matthew D Marsden; Michael Kovochich; Nuttee Suree; Saki Shimizu; Roshni Mehta; Ruth Cortado; Gregory Bristol; Dong Sung An; Jerome A Zack
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  HIV reservoirs and latency models.

Authors:  Matthew J Pace; Luis Agosto; Erin H Graf; Una O'Doherty
Journal:  Virology       Date:  2011-02-01       Impact factor: 3.616

3.  Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo.

Authors:  Zhenya Ni; David A Knorr; Laura Bendzick; Jeremy Allred; Dan S Kaufman
Journal:  Stem Cells       Date:  2014-04       Impact factor: 6.277

Review 4.  New generation humanized mice for virus research: comparative aspects and future prospects.

Authors:  Ramesh Akkina
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

Review 5.  Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.

Authors:  Jiehua Zhou; John Rossi
Journal:  J Investig Med       Date:  2014-10       Impact factor: 2.895

6.  An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription.

Authors:  Sheena Saayman; Amanda Ackley; Anne-Marie W Turner; Marylinda Famiglietti; Alberto Bosque; Matthew Clemson; Vicente Planelles; Kevin V Morris
Journal:  Mol Ther       Date:  2014-02-28       Impact factor: 11.454

7.  Modeling the evolution of SIV sooty mangabey progenitor virus towards HIV-2 using humanized mice.

Authors:  Kimberly Schmitt; Dipu Mohan Kumar; James Curlin; Leila Remling-Mulder; Mark Stenglein; Shelby O'Connor; Preston Marx; Ramesh Akkina
Journal:  Virology       Date:  2017-07-24       Impact factor: 3.616

8.  A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.

Authors:  Paige Charlins; Kimberly Schmitt; Leila Remling-Mulder; Louise E Hogan; Emily Hanhauser; Kristen S Hobbs; Frederick Hecht; Steven G Deeks; Timothy J Henrich; Ramesh Akkina
Journal:  Virology       Date:  2017-04-19       Impact factor: 3.616

9.  In vivo blockade of the PD-1 receptor suppresses HIV-1 viral loads and improves CD4+ T cell levels in humanized mice.

Authors:  Brent E Palmer; C Preston Neff; Jonathan Lecureux; Angelica Ehler; Michelle Dsouza; Leila Remling-Mulder; Alan J Korman; Andrew P Fontenot; Ramesh Akkina
Journal:  J Immunol       Date:  2012-12-03       Impact factor: 5.422

10.  Mucosal tissue pharmacokinetics of the integrase inhibitor raltegravir in a humanized mouse model: Implications for HIV pre-exposure prophylaxis.

Authors:  Milena Veselinovic; Kuo-Hsiung Yang; Craig Sykes; Leila Remling-Mulder; Angela D M Kashuba; Ramesh Akkina
Journal:  Virology       Date:  2016-01-06       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.